Dominique Breilh
-
- Antibiotic Use and Resistance 8
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 22
- Virology top 2%
- HIV Research and Treatment 15
- Pharmacology top 0.5%
- Antibiotics Pharmacokinetics and Efficacy 44
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 14
- HIV/AIDS Research and Interventions 7
-
- Pneumonia and Respiratory Infections 17
-
- Pharmaceutical Practices and Patient Outcomes 6
- Co-authors
- Marie‐Claude SauxBernard AllaouchicheEmmanuel BoselliD. ChassardSarah DjabaroutiThomas RimmeléFabien XuerebJean-Baptiste Gordien
- Journals
- Antimicrobial Agents and Chemotherapy (6 papers)Critical Care Medicine (5 papers)International Journal of Pharmaceutics (1 paper)
- Partner nations
- FranceUnited StatesBelize
In The Last Decade
Dominique Breilh
86 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 110
- Applied Microbiology and Biotechnology 283
- Molecular Medicine 542
- Virology 379
- Pharmacology 1.2k
- Infectious Diseases 809
Countries citing papers authored by Dominique Breilh
This map shows the geographic impact of Dominique Breilh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominique Breilh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominique Breilh more than expected).
Fields of papers citing papers by Dominique Breilh
This network shows the impact of papers produced by Dominique Breilh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominique Breilh. The network helps show where Dominique Breilh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dominique Breilh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2020 | 20 | |
| 3 | 2018 | 48 | |
| 4 | 2017 | 84 | |
| 5 | 2014 | 6 | |
| 6 | 2011 | 4 | |
| 7 | 2010 | 54 | |
| 8 | 2009 | 84 | |
| 9 | 2009 | 22 | |
| 10 | 2008 | 4 | |
| 11 | 2006 | 65 | |
| 12 | 2005 | 45 | |
| 13 | 2005 | 128 | |
| 14 | 2004 | 28 | |
| 15 | 2003 | 23 | |
| 16 | 2003 | 32 | |
| 17 | 2001 | 9 | |
| 18 | 1999 | 34 | |
| 19 | 1999 | 5 | |
| 20 | 1998 | 38 |
About Dominique Breilh
Dominique Breilh is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Medical Terminology, having authored 92 papers that have together received 2.4k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (44 papers), Antibiotic Resistance in Bacteria (22 papers), Pneumonia and Respiratory Infections (17 papers), HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (14 papers), Antibiotic Use and Resistance (8 papers), HIV/AIDS Research and Interventions (7 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (283 citations), Molecular Medicine (542 citations) and Virology (379 citations). Dominique Breilh has collaborated with scholars based in France, United States and Belize. Frequent co-authors include Marie‐Claude Saux, Bernard Allaouchiche, Emmanuel Boselli, D. Chassard, Sarah Djabarouti, Thomas Rimmelé, Fabien Xuereb, Jean-Baptiste Gordien, Hervé Fleury and Jean‐Luc Pellegrin. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Critical Care Medicine and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.